Uso racional de medicamentos: temas selecionados, 2012.

21. GONZÁLEZ-ORTIZ, M. et al. Efficacy of
glimepiride/metformin combination versus
glibenclamide/ metformin in patients with
uncontrolled type 2 diabetes mellitus. Journal of
Diabetes and its Complications, New York, v. 23,
n. 6, p. 376-379, 2009.
22. ALVARSSON, M. et al. Effects of insulin vs.
glibenclamide in recently diagnosed patients
with type 2 diabetes: a 4-year follow-up.
Diabetes, Obesity & Metabolism, Oxford, v. 10,
n. 5, p. 421-429, 2008.
23. GOTTSCHALK, M. et al. Glimepiride versus
metformin as monotherapy in pediatric patients
with type 2 diabetes: a randomized, single-blind
comparative study. Diabetes Care, New York, v.
30, n. 4, p. 790-794, 2007.
24. SAENZ, A. et al. Metformin monotherapy
for type 2 diabetes mellitus. Cochrane
Database of Systematic Reviews, Oxford, n.12,
2010. CD002966.
25. SALPETER, S.R. et al. Risk of fatal and
nonfatal lactic acidosis with metformin use in
type 2 diabetes mellitus. Cochrane Database
of Systematic Reviews, Oxford, n. 12, 2010.
CD002967.
26. SILVA, J.C. et al. Metformin compared with
glyburide for the management of gestational diabetes.
International Journal of Gynaecology and
Obstetrics, New York, v. 111, n. 1, p. 37-40, 2010.
Ministério da Saúde
130
27. KANE, M.P.; ABU-BAKER, A.; BUSCH, R.S.
The utility of oral diabetes medications in type
2 diabetes of the young. Current Diabetes
Reviews, Saif Zone, v. 1, n. 1, p. 83-92, 2005.
28. QUINN, S.M. et al. Treatment of clinical
insulin resistance in children: a systematic review.
Obesity Reviews, Oxford, v. 11,
n. 10, p. 722-730, 2010.
29. ABDELGHAFFAR, S.; ATTIA, A.M. Metformin
added to insulin therapy for type 1 diabetes
mellitus in adolescents. Cochrane Database
of Systematic Reviews, Oxford, n. 12, 2010.
CD006691.
30. PARK, M.H. et al. Metformin for obesity in
children and adolescents: a systematic review.
Diabetes Care, New York, v. 32, n. 9, p. 1743-
1745, 2009.
31. WILSON, D.M. et al. Metformin extended
release treatment of adolescent obesity: a
48-week randomized, double-blind, placebocontrolled
trial with 48-week follow-up. Archives
of Pediatrics & Adolescent Medicine, Chicago,
v. 164, n. 2, p. 116-123, 2010. Glaser Pediatric
Research Network Obesity Study Group.
32. WIEGAND, S. et al. Metformin and placebo
therapy both improve weight management
and fasting insulin in obese insulin-resistant
adolescents: a prospective, placebo-controlled,
randomized study. European Journal of
Endocrinology, Oslo, v. 63, n. 4, p. 585-592, 2010.